V družbi MSD že več kot stoletje odkrivamo in razvijamo zdravila ter cepiva za najbolj zahtevne bolezni na svetu. Vedno smo bili inovativni in takšni tudi ostajamo, in sicer z enim samim namenom ― odkrivati za življenje.

ZAKAJ ODKRIVAMO ZA ŽIVLJENJE

Spopadamo se s številnimi svetovno najzahtevnejšimi boleznimi, saj svet še vedno potrebuje zdravilo za raka, Alzheimerjevo bolezen, HIV in mnoge druge bolezni, ki povzročajo trpljenje ljudem ter živalim po vsem svetu. Ljudem pomagamo neobremenjeno ustvarjati, živeti in uživati svoje življenje.

Oglejte si, kako zaposleni v družbi MSD vidijo svoje poslanstvo

NAŠ DOPRINOS

RAZVIJAMO NOVE PRISTOPE ZA
PREPREČEVANJE IN ZDRAVLJENJE RAKA

Odkrivamo nove načine, kako zdraviti rakava obolenja. Naše raziskave na področju imunoonkologije so najbolj številčne v industriji. Eden izmed naših ciljev pa je spremeniti, kako se soočamo z zdravljenjem rakavih obolenj.

PREPREČUJEMO ŽIVLJENJSKO OGROŽUJOČE BOLEZNI

Že več kot stoletje odkrivamo in razvijamo cepiva, ki pomagajo ščititi otroke, mladostnike in odrasle pred številnimi nalezljivimi boleznimi.

POMAGAMO IZBOLŠATI ŽIVLJENJA BOLNIKOV S SLADKORNO BOLEZNIIJO

Ne osredotočamo se samo na vlaganja v raziskave, ampak tudi v podporo bolnikom.

PREPREČUJEMO IN ZDRAVIMO NALEZLJIVE BOLEZNI

Vse večja odpornost bakterij na antibiotike je postala ena največjih svetovnih javnozdravstvenih izzivov. Smo ena redkih družb, ki še vedno vlaga v preučevanje antibiotikov in odgovorne uporabe protimikrobnih zdravil.

BORIMO SE PROTI ALZHEIMERJEVI BOLEZNI

Zavzemamo se, da bomo znanost svetovnega kova prenesli na preučevanje Alzheimerjeve bolezni, ki vsako leto vse več ljudem odvzame spomine in identiteto. Posvečamo se nadaljnjemu razvoju, kako preprečiti Alzheimerjevo bolezen ter pri tem porabiti pridobljeno znanje iz kliničnih študij.

chevron_right

chevron_left

Forward-Looking Statement

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.